AlphaQuest LLC Grows Holdings in Agilent Technologies, Inc. $A

AlphaQuest LLC boosted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 3,491.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 28,484 shares of the medical research company’s stock after acquiring an additional 27,691 shares during the period. AlphaQuest LLC’s holdings in Agilent Technologies were worth $3,876,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the company. Flynn Zito Capital Management LLC lifted its position in shares of Agilent Technologies by 3.2% in the third quarter. Flynn Zito Capital Management LLC now owns 2,257 shares of the medical research company’s stock valued at $290,000 after acquiring an additional 69 shares in the last quarter. Gabelli Funds LLC lifted its holdings in Agilent Technologies by 1.1% in the 3rd quarter. Gabelli Funds LLC now owns 6,620 shares of the medical research company’s stock worth $850,000 after purchasing an additional 74 shares in the last quarter. Fiduciary Trust Co lifted its holdings in Agilent Technologies by 1.6% in the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock worth $633,000 after purchasing an additional 77 shares in the last quarter. NorthCrest Asset Manangement LLC boosted its stake in Agilent Technologies by 1.6% in the 4th quarter. NorthCrest Asset Manangement LLC now owns 5,082 shares of the medical research company’s stock worth $726,000 after purchasing an additional 79 shares during the period. Finally, Freestone Capital Holdings LLC boosted its stake in Agilent Technologies by 2.0% in the 4th quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock worth $574,000 after purchasing an additional 84 shares during the period.

Agilent Technologies Trading Up 0.0%

Shares of A stock opened at $115.01 on Tuesday. The company has a market cap of $32.50 billion, a PE ratio of 25.39, a price-to-earnings-growth ratio of 2.42 and a beta of 1.22. Agilent Technologies, Inc. has a 1 year low of $107.07 and a 1 year high of $160.27. The stock’s 50 day simple moving average is $114.84 and its two-hundred day simple moving average is $129.23. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). The company had revenue of $1.80 billion during the quarter, compared to analysts’ expectations of $1.81 billion. Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.Agilent Technologies’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Research analysts predict that Agilent Technologies, Inc. will post 5.95 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.255 per share. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. Agilent Technologies’s payout ratio is 22.52%.

Wall Street Analyst Weigh In

A has been the topic of several recent analyst reports. UBS Group reduced their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Morgan Stanley dropped their target price on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. Wall Street Zen cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Wells Fargo & Company reduced their price target on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a report on Thursday, February 26th. Finally, Barclays decreased their price target on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $163.71.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.